Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Kanamycin Market by Type (Injection, Solution), By Application (Medical, Santific Research, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Kanamycin Market by Type (Injection, Solution), By Application (Medical, Santific Research, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 197588 3300 Chemical & Material 377 240 Pages 4.5 (39)
                                          

Market Overview:


The global kanamycin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for kanamycin due to its antimicrobial properties and rising prevalence of infectious diseases. In addition, the growing use of kanamycin in medical and scientific research applications is also contributing to the growth of this market. However, factors such as stringent regulatory requirements and high costs associated with R&D are restraining the growth of this market. On the basis of type, the global kanamycin market can be segmented into injection and solution products. The injection product segment is expected to account for a larger share than that of solution products in terms revenue contribution during 2018-2030 owing higher adoption rates across various end-use industries including medical, scientific research, and others segments collectively).


Global Kanamycin Industry Outlook


Product Definition:


A bacteriostatic antibiotic produced by Streptomyces kanamyceticus, used to treat a wide variety of infections.


Injection:


Injection is a method of medication that involves the administration of drugs into the bloodstream through syringes or intravenous catheters. Injectables are different from oral medications in terms of their mode of action and site of action. The drug absorption process in injectables is rapid, which offers an advantage to this form over other dosage forms; it allows for higher doses to be administered without having an adverse effect on the patient's health.


Solution:


Kanamycin is a type of antimicrobial drug used to treat bacterial infections. It works by killing the bacteria. The most common types of bacterial infections that kenneths lawsonia dolioides (lawsonia bug) can cause are ear, eye, and skin infections; pneumonia; and bloodstream infection. Kanamycin has been approved by the Food and Drug Administration (FDA) for use as a prescription drug in the U.S.


Application Insights:


Medical application of kanamycin includes the use of injection for the treatment of infections caused by susceptible bacteria. The medical segment held a major share in 2015 and is expected to maintain its dominance over the forecast period. This is attributed to extensive usage as an antibiotic for various diseases, such as tuberculosis, skin infections, respiratory tract infections, UTI's (urinary tract infection), ear infection etc. It has also been used in surgical procedures and can be used against drug-resistant bacteria & viruses.


The other segment comprises research applications where kanamycin is used for scientific research purposes or animal testing purposes only; it does not have any commercial application whatsoever.


Regional Analysis:


Asia Pacific dominated the global market in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing R&D activities and rising healthcare spending in emerging economies such as China, India, and South Korea. In addition, growing awareness regarding kanamycin-based products among healthcare professionals and patients is further expected to drive demand for kanamycin in this region.


In addition, favorable government initiatives pertaining to research & development activities are also anticipated to propel growth of the Asia Pacific market during the forecast period. For instance; ‘Make in India’ initiative by Indian government aims at promoting manufacturing sector within country which will create job opportunities for skilled labor thus driving demand for kanamycin-based drugs over next few years .


Growth Factors:


  • Increasing demand for kanamycin in the pharmaceutical and biotechnology industries for the manufacture of antibiotics, antitumor drugs, and other therapeutic agents.
  • Rising prevalence of infectious diseases that are treated with kanamycin-based antibiotics.
  • Growing demand for kanamycin as a research tool in the fields of molecular biology and genetics.
  • increasing use of kanamycin as a feed additive to promote livestock growth and improve meat quality . 5

Scope Of The Report

Report Attributes

Report Details

Report Title

Kanamycin Market Research Report

By Type

Injection, Solution

By Application

Medical, Santific Research, Other

By Companies

Thermo Fisher, Sigma-Aldrich, HiMedia, Atlanta Biologicals, Takara, PromoCell, Zenbio, Abcam

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

240

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Kanamycin Market Report Segments:

The global Kanamycin market is segmented on the basis of:

Types

Injection, Solution

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Medical, Santific Research, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Thermo Fisher
  2. Sigma-Aldrich
  3. HiMedia
  4. Atlanta Biologicals
  5. Takara
  6. PromoCell
  7. Zenbio
  8. Abcam

Global Kanamycin Market Overview


Highlights of The Kanamycin Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Injection
    2. Solution
  1. By Application:

    1. Medical
    2. Santific Research
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Kanamycin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Kanamycin Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Kanamycin is a type of antibiotic that is used to treat infections. It works by killing the bacteria cells that are causing the infection. Kanamycin can be taken by mouth or injected into a vein.

Some of the key players operating in the kanamycin market are Thermo Fisher, Sigma-Aldrich, HiMedia, Atlanta Biologicals, Takara, PromoCell, Zenbio, Abcam.

The kanamycin market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Kanamycin Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Kanamycin Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Kanamycin Market - Supply Chain
   4.5. Global Kanamycin Market Forecast
      4.5.1. Kanamycin Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Kanamycin Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Kanamycin Market Absolute $ Opportunity

5. Global Kanamycin Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Kanamycin Market Size and Volume Forecast by Type
      5.3.1. Injection
      5.3.2. Solution
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Kanamycin Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Kanamycin Market Size and Volume Forecast by Application
      6.3.1. Medical
      6.3.2. Santific Research
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Kanamycin Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Kanamycin Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Kanamycin Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Kanamycin Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Kanamycin Demand Share Forecast, 2019-2026

9. North America Kanamycin Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Kanamycin Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Kanamycin Market Size and Volume Forecast by Application
      9.4.1. Medical
      9.4.2. Santific Research
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Kanamycin Market Size and Volume Forecast by Type
      9.7.1. Injection
      9.7.2. Solution
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Kanamycin Demand Share Forecast, 2019-2026

10. Latin America Kanamycin Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Kanamycin Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Kanamycin Market Size and Volume Forecast by Application
      10.4.1. Medical
      10.4.2. Santific Research
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Kanamycin Market Size and Volume Forecast by Type
      10.7.1. Injection
      10.7.2. Solution
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Kanamycin Demand Share Forecast, 2019-2026

11. Europe Kanamycin Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Kanamycin Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Kanamycin Market Size and Volume Forecast by Application
      11.4.1. Medical
      11.4.2. Santific Research
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Kanamycin Market Size and Volume Forecast by Type
      11.7.1. Injection
      11.7.2. Solution
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Kanamycin Demand Share, 2019-2026

12. Asia Pacific Kanamycin Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Kanamycin Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Kanamycin Market Size and Volume Forecast by Application
      12.4.1. Medical
      12.4.2. Santific Research
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Kanamycin Market Size and Volume Forecast by Type
      12.7.1. Injection
      12.7.2. Solution
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Kanamycin Demand Share, 2019-2026

13. Middle East & Africa Kanamycin Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Kanamycin Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Kanamycin Market Size and Volume Forecast by Application
      13.4.1. Medical
      13.4.2. Santific Research
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Kanamycin Market Size and Volume Forecast by Type
      13.7.1. Injection
      13.7.2. Solution
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Kanamycin Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Kanamycin Market: Market Share Analysis
   14.2. Kanamycin Distributors and Customers
   14.3. Kanamycin Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Thermo Fisher
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Sigma-Aldrich
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. HiMedia
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Atlanta Biologicals
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Takara
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. PromoCell
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Zenbio
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Abcam
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us